Comments regarding use of rifabutin for eradication

by David Y. Graham
Published 2021-10-01

Implications of the paradigm shift in management of infections

by David Y. Graham
Published 2023-03-01

Transitioning of <i>Helicobacter pylori</i> Therapy from Trial and Error to Antimicrobial Stewardship

by David Y. Graham
Published 2020-10-01

Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for <i>Helicobacter pylori</i> Therapy

by David Y. Graham
Published 2024-02-01

Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: A mini review

by David Y. Graham, Muhammad Miftahussurur
Published 2018-09-01

Furazolidone in Helicobacter pylori therapy: Misunderstood and often unfairly maligned drug told in a story of French bread

by David Y Graham, Hong Lu
Published 2012-01-01

Review: A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers

by Sandy H. Pang, David Y. Graham
Published 2010-01-01

Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?

by David Y Graham, Hong Lu, Akiko Shiotani
Published 2017-01-01

Toothpick Perforation of the Intestines Presenting as Recurrent Abdominal Pain: Possible Roles of Abdominal Ultrasound and MRI

by Robert J. Sealock, Saman Sabounchi, David Y. Graham
Published 2013-07-01

Toothpick Perforation of the Intestines Presenting as Recurrent Abdominal Pain: Possible Roles of Abdominal Ultrasound and MRI

by Robert J. Sealock, Saman Sabounchi, David Y. Graham
Published 2013-01-01

diagnosis and therapy in the era of antimicrobial stewardship

by Akiko Shiotani, Priya Roy, Hong Lu, David Y. Graham
Published 2021-12-01

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial

by Ira N. Kalfus, David Y. Graham, Dennis S. Riff, Raymond M. Panas
Published 2020-10-01

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea

by WonGun Kwack, YunJeong Lim, ChiYeon Lim, David Y. Graham
Published 2016-01-01

Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor

by Maria Pina Dore, Stefano Bibbò, Giovanni Mario Pes, Ruggero Francavilla, David Y. Graham
Published 2019-01-01

Identification of the genes that contribute to lactate utilization in Helicobacter pylori.

by Shun Iwatani, Hiroyuki Nagashima, Rita Reddy, Seiji Shiota, David Y Graham, Yoshio Yamaoka
Published 2014-01-01

Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR.

by Khitam Muhsen, Rosanna Lagos, Mardi K Reymann, David Y Graham, Marcela F Pasetti, Myron M Levine
Published 2014-01-01

Helicobacter, Hygiene, Atopy, and Asthma

by Muhammad Miftahussurur, Muhammad Miftahussurur, Muhammad Miftahussurur, Iswan A. Nusi, David Y. Graham, Yoshio Yamaoka, Yoshio Yamaoka
Published 2017-06-01

Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).

by Alba A Trespalacios-Rangél, William Otero, Azucena Arévalo-Galvis, Raúl A Poutou-Piñales, Emiko Rimbara, David Y Graham
Published 2016-01-01

Susceptibility-guided therapy for infection treatment failures

by Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, Qi Chen, Yanyan Song, Xiaobo Li, David Y. Graham, Hong Lu
Published 2019-09-01

Norwalk Virus Shedding after Experimental Human Infection

by Robert L. Atmar, Antone R. Opekun, Mark A. Gilger, Mary K. Estes, Sue E. Crawford, Frederick H. Neill, David Y. Graham
Published 2008-10-01